Billing Codes

CCSD Code B0900: Operations on Aberrant Thyroid Tissue

Key Takeaways

Key Takeaways

CCSD Code B0900 covers operations on aberrant thyroid tissue, including excision and removal of retrosternal goitre, under the UK private healthcare CCSD Schedule of Procedures.

B0900 is a high-complexity, Band 16 procedure: Guernsey’s 2026 tariff is £12,355, reflecting the surgical complexity involved in aberrant thyroid tissue removal.

Major UK private medical insurers including Bupa, AXA Health, and Allianz Care recognise CCSD codes; always verify current fee schedules directly with each insurer before submitting claims.

Pabau’s claims management software supports CCSD code submission via Healthcode, helping UK private practices reduce claim errors and accelerate reimbursement for complex surgical procedures.

Most CCSD claim rejections for complex thyroid procedures come down to one issue: incomplete operative documentation. Billing staff submit B0900 without a clear record of the surgical approach, the anatomical location of aberrant tissue, or whether a concurrent procedure was performed. The insurer flags it, the claim sits in a queue, and revenue recovery stalls by weeks. This reference guide covers CCSD Code B0900 for clinic billing teams and practice managers handling UK private healthcare claims for aberrant thyroid surgery.

The article covers the code’s clinical definition, how it sits within the CCSD Schedule of Procedures, documentation requirements, insurer-specific considerations, related thyroid codes, and practical billing workflow guidance using Pabau’s claims management software.

CCSD Code B0900: Definition and Clinical Description

CCSD Code B0900 is defined in the CCSD Schedule of Procedures as “Operations on aberrant thyroid tissue (including excision/removal of retrosternal goitre).” The code captures a range of surgical interventions targeting thyroid tissue that has developed in an anatomically abnormal location, most commonly within the mediastinum or chest cavity (retrosternal position), but also potentially at the base of the tongue or along the embryological descent path of the thyroid gland.

Aberrant thyroid tissue is functionally distinct from the main thyroid gland. It represents ectopic thyroid tissue that failed to migrate correctly during foetal development. Surgically, these procedures tend to be more complex than standard thyroidectomy because of proximity to vascular structures and the mediastinal approach that retrosternal cases often require. This clinical complexity is reflected in B0900’s classification as a high-band procedure in published tariff schedules. The code is maintained by the Clinical Coding and Schedule Development (CCSD) group and appears in the procedural chapter covering endocrine and thyroid surgery.

Fee Schedules and Reimbursement for B0900

B0900 sits at the upper end of the CCSD procedural tariff range. Fee data from published schedules illustrates the reimbursement levels that private providers may expect, though actual insurer rates vary and should always be confirmed directly with the relevant payer.

Schedule / Insurer Fee / Band Notes
Guernsey Private Fee Schedule 2026 £12,355 (Band 16) Highest available published tariff; Band 16 denotes maximum surgical complexity
Guernsey Private Fee Schedule 2021 £9,500 Historical reference; illustrates tariff uplift over 5-year period
Bupa (UK) Insurer-specific; verify via portal Use Bupa code search for current recognised fee
AXA Health (UK) Insurer-specific; verify via portal Check AXA Health specialist procedure codes for contracted fees
Allianz Care UK Published national fee schedule Uses CCSD codes as the basis for all procedure coding; effective December 2024

These figures are reference points only. UK private medical insurers set their own contracted rates for recognised providers, and fees may differ materially from published tariff guides. For accurate reimbursement figures, check each insurer’s portal directly. Providers interested in how UK private billing compares across insurer types can also review the Bupa procedure codes fee schedule guide for broader context on CCSD-based pricing structures.

Documentation Requirements for Aberrant Thyroid Surgery

B0900 claims carry a higher documentation burden than routine outpatient procedures. Insurers require clear operative evidence that the procedure performed matches the code’s narrative. Three documentation elements consistently determine whether a B0900 claim is processed cleanly or queried.

  • Operative note confirming aberrant tissue location: The report must explicitly state that tissue was identified in an anatomically aberrant position (for example, retrosternal, mediastinal, or lingual). A generic thyroidectomy note will not support a B0900 claim.
  • Surgical approach recorded: For retrosternal goitre removal, document whether a sternotomy or cervical approach was used. This matters for unbundling reviews and any concurrent procedure coding.
  • Histopathology reference: Where a specimen was sent for analysis, reference the histopathology request in the operative note. This strengthens the clinical record and supports the aberrant tissue designation.
  • Pre-operative imaging cited: CT or ultrasound findings that identified the aberrant tissue should be cited. This creates an audit trail from diagnosis through to procedure.
  • Consent documentation: Informed consent specific to the surgical approach and associated risks (recurrent laryngeal nerve injury, mediastinal surgery complications) should be in the patient record.

Using digital clinical forms that capture these elements at the point of care reduces the risk of retrospective documentation gaps. Structured operative note templates help billing staff verify that all required fields are completed before a claim is submitted.

Pro Tip

Run a documentation checklist before submitting any B0900 claim. Confirm the operative note includes: aberrant tissue location, surgical approach, histopathology reference, and pre-operative imaging citation. A 10-minute pre-submission review reduces insurer query rates significantly.

Insurer Recognition and Submission for CCSD Code B0900

All major UK private medical insurers (PMIs) use the CCSD Schedule as the standard basis for procedure coding. B0900 is a recognised procedural code, but insurer-specific rules govern how claims are processed. The key variables are: prior authorisation requirements, whether the insurer applies any bundling restrictions for concurrent procedures, and which contracted fee applies to the treating clinician’s recognition status.

Practices billing through Bupa should verify code recognition and the applicable fee via the Bupa code search tool before invoicing. AXA Health publishes its procedure schedule via a dedicated portal for fee-approved specialists. For Allianz Care, the published UK Recognition Fee Schedule (effective December 2024) lists all CCSD-coded procedures. Practices new to UK private billing can review the Bupa CCSD codes guide for a broader introduction to how the CCSD system works across major insurers.

Electronic submission via Healthcode is the standard route for UK private healthcare claims. Healthcode’s platform accepts CCSD-coded invoices and routes them to the relevant insurer. Clinics that manage their private practice billing through an integrated system can submit claims directly without manual re-entry, reducing transcription errors that commonly cause B0900 claim rejections.

Streamline CCSD Billing for Complex Surgical Procedures

Pabau integrates with Healthcode to support CCSD code submission for UK private practices. Submit B0900 and other complex surgical claims with structured documentation, automated workflows, and real-time claim tracking.

Pabau claims management dashboard for UK private healthcare billing

Modifier Usage and Bundling Considerations

B0900 covers the complete operation on aberrant thyroid tissue. When a surgeon also performs a separate, distinct procedure during the same operative session, separate coding of that procedure may be appropriate, depending on the insurer’s bundling rules. Common scenarios include:

  • Concurrent parathyroidectomy (B1450): If parathyroid tissue is excised during the same session and this is clinically documented as a separate procedure, B1450 may be reported alongside B0900. Always confirm with the specific insurer whether concurrent coding is accepted.
  • Frozen section / intraoperative pathology: Where intraoperative frozen section analysis is performed, this may attract a separate diagnostic code. Refer to the CCSD technical guide for current guidance on concurrent diagnostic coding.
  • Anaesthetic codes: Anaesthetic fees are typically billed separately by the anaesthetist under their own CCSD codes. The surgical B0900 claim covers the surgeon’s fee only.

Avoid coding B0900 alongside standard thyroidectomy codes (such as those covering total or partial thyroid removal) for the same operative session without clinical justification. Insurers may interpret this as duplicate billing. When in doubt, contact the insurer’s provider relations team before submitting a complex concurrent claim. Practices managing multiple complex surgical claims would benefit from reviewing surgical clinic operations guidance for broader private practice billing context.

Pro Tip

Check each insurer’s concurrent procedure rules before coding B0900 alongside any parathyroid or thyroid code. Bupa, AXA Health, and Allianz Care each publish their own unbundling guidance. A quick portal check before submission prevents the most common reason for B0900 claim queries.

B0900 sits within a cluster of CCSD thyroid and endocrine procedure codes. Understanding the boundaries between these codes prevents miscoding and supports accurate claim submission for practices handling a range of thyroid surgical cases. The following table summarises the most commonly encountered related codes.

CCSD Code Procedure Description How It Differs from B0900
B0900 Operations on aberrant thyroid tissue (including retrosternal goitre) The reference code for ectopic/aberrant thyroid tissue surgery
B1012 Excision of thyroglossal cyst or tract Covers thyroglossal duct remnants, not aberrant thyroid tissue; anatomically distinct
B1220 Fine needle aspiration (FNA) of thyroid gland Diagnostic, minimally invasive; cannot substitute for B0900 in surgical claims
B1230 Core biopsy of thyroid gland Diagnostic biopsy of the main gland; not applicable to aberrant tissue excision
B1250 Thyroid: re-operation Used for repeat thyroid surgery on the main gland; separate clinical indication
B1450 Parathyroidectomy Covers parathyroid gland removal; may be concurrent but is a distinct code

Accurate code selection depends on whether the operative note confirms tissue as anatomically aberrant (B0900) versus a thyroglossal remnant (B1012) or the main thyroid gland (various B12xx codes). When clinical records are ambiguous, seek clarification from the operating surgeon before coding. For a broader overview of CCSD procedure codes across surgical specialties, the Pabau procedure codes library provides additional reference material. Practices managing endocrine surgical billing alongside plastic and reconstructive procedures may also find the plastic surgery practice management resource useful for broader context.

Expert Picks

Expert Picks

Need a practical guide to Bupa CCSD codes for UK private practice? Bupa CCSD Codes: Complete Guide for UK Clinics covers how to find the right code, avoid common pitfalls that trigger claim denials, and streamline your billing with electronic submission.

Looking for end-to-end claims management for UK private healthcare? Pabau Claims Management Software supports CCSD code submission via Healthcode, with structured workflows designed to reduce rejection rates for complex surgical claims.

Considering the transition to UK private practice? Leaving the NHS for Private Practice covers the billing, compliance, and operational considerations for clinicians moving into the private sector, including CCSD coding requirements.

Conclusion

Aberrant thyroid surgery is one of the more clinically complex procedures in the CCSD Schedule, and billing errors for B0900 almost always trace back to incomplete operative documentation or uncertainty about concurrent procedure rules. Getting the documentation right before submission, and verifying insurer-specific rates and bundling policies, are the two levers that most directly affect clean claim rates for this code.

Pabau’s claims management software helps UK private practices submit CCSD-coded claims via Healthcode with structured documentation workflows that reduce the most common rejection triggers. To see how Pabau handles complex surgical billing for private clinics, book a demo.

Frequently Asked Questions

What does CCSD Code B0900 cover?

CCSD Code B0900 covers operations on aberrant thyroid tissue, including excision and removal of retrosternal goitre. It applies to surgical interventions on ectopic thyroid tissue located outside the normal anatomical position, most commonly in the mediastinum or chest cavity. It does not cover standard thyroidectomy or thyroglossal cyst excision, which have separate CCSD codes.

How much does a B0900 procedure cost under private insurance in the UK?

Published tariff data shows a range: Guernsey’s 2021 schedule listed £9,500 and the 2026 schedule shows £12,355 (Band 16). UK insurer rates (Bupa, AXA Health, Allianz Care) vary by provider recognition status and contracted fee schedule. Always verify the applicable fee directly with the insurer before submitting a claim, as contracted rates may differ from published tariffs.

Which UK insurers recognise CCSD Code B0900?

All major UK private medical insurers that use the CCSD Schedule recognise B0900, including Bupa, AXA Health, Allianz Care, Vitality Health, WPA, and Healix. Recognition does not guarantee payment at a specific rate; the contracted fee depends on the provider’s recognition agreement with each insurer. Verify recognition status and the applicable fee via each insurer’s provider portal before billing.

What documentation is required for a B0900 claim?

A B0900 claim requires an operative note explicitly confirming the aberrant location of the tissue (for example, retrosternal or mediastinal), the surgical approach used, a reference to any histopathology sent, and cited pre-operative imaging that identified the tissue. Informed consent records specific to the procedure should also be in the patient file. Missing any of these elements is the most common reason B0900 claims are queried or rejected.

What is the difference between B0900 and B1012?

B0900 covers operations on aberrant thyroid tissue (ectopic thyroid tissue in an abnormal location), while B1012 covers excision of a thyroglossal cyst or tract (a remnant of the thyroglossal duct from embryological development). Although both involve abnormal thyroid-related anatomy, they are clinically and anatomically distinct. Using B1012 for a retrosternal goitre excision, or B0900 for a thyroglossal cyst removal, would represent a coding error and is likely to result in a claim query.

×